Year : 2013 | Volume
| Issue : 2 | Page : 181-186
The comparative evaluation of intravenous with intramuscular clonidine for suppression of hemodynamic changes in laparoscopic cholecystectomy
Meena Singh1, Arin Choudhury2, Manpreet Kaur1, Dootika Liddle2, Mary Verghese2, Ira Balakrishnan1
1 Department of Anaesthesia and Critical Care, JPNA Trauma Centre, All India Institute of Medical Sciences, New Delhi, India
2 Department of Anaesthesia and Critical Care, Christian Medical College, Ludhiana, Punjab, India
F-118 Ansari Nagar (West), AIIMS residential quarters, New Delhi - 110 029
Source of Support: None, Conflict of Interest: None
|Date of Web Publication||26-Jun-2013|
Background: Clonidine diminishes stress response by reducing circulating catecholamines and hence increases perioperative circulatory stability in patients undergoing laparoscopic surgeries. The aim of this study was to compare intravenous (IV) clonidine (2 μg/kg) with intramuscular (IM) clonidine (2 μg/kg) for attenuation of stress response in laproscopic surgeries. Methods: Eighty adult patients classified as ASA physical status I or II, aged between 20 and 60 years undergoing elective cholecystectomy under general anesthesia were enrolled for a prospective, randomized, and double-blind controlled trial. They received either IV clonidine (2 μg/kg) 15 min prior to the scheduled surgery (Group I) or IM clonidine (2 μg/kg) 60-90 min prior to the scheduled surgery (Group II). Hemodynamic variables (Heart rate, systolic (SBP), diastolic (DBP), mean arterial pressure (MAP)), SpO 2 and EtCO 2 were recorded at specific times - baseline, prior to induction, 1 min after intubation, before CO 2 , insufflation, after CO 2 insufflation at 1,5,10,20,30,45,60 min, after release of CO 2 , at 1 and 10 minutes after extubation. Secondary outcomes included evaluation of adverse effect profile of the two groups. Results: No significant difference was observed in the HR throughout the intraoperative period in between the two groups (P>0.05). There was statistically significant difference in SBP between the two groups starting from 1 minute after induction till 1 min after extubation (P<0.05) but not in DBP except at 1 minute after intubation (P=0.042). Significant difference in MAP was noted at 1 minute after intubation (P=0.004) and then from 5 minutes after CO 2 insufflation to 1 minute after extubation (P<0.05). Incidence of adverse effects were higher in group II (P=0.02) especially incidence of hypertension requiring treatment (0.006). Conclusion: We conclude that under the conditions of this study, hemodynamic parameters (SBP, DBP and MAP) were better maintained in the IV as compared to the IM route that had significantly higher incidence of hypertension requiring treatment.
Keywords: Clonidine, hemodynamic response, laproscopic cholecystectomy, pneumoperitoneum, stress response
|How to cite this article:|
Singh M, Choudhury A, Kaur M, Liddle D, Verghese M, Balakrishnan I. The comparative evaluation of intravenous with intramuscular clonidine for suppression of hemodynamic changes in laparoscopic cholecystectomy. Saudi J Anaesth 2013;7:181-6
|How to cite this URL:|
Singh M, Choudhury A, Kaur M, Liddle D, Verghese M, Balakrishnan I. The comparative evaluation of intravenous with intramuscular clonidine for suppression of hemodynamic changes in laparoscopic cholecystectomy. Saudi J Anaesth [serial online] 2013 [cited 2023 Feb 9];7:181-6. Available from: https://www.saudija.org/text.asp?2013/7/2/181/114070
| Introduction|| |
The laparoscopic approach for both diagnostic and operative surgeries is considered to be safe and reliable technique with several advantages over the standard open procedures. , However, it is not completely safe in the elderly and is hemodynamically compromised. During laparoscopy, the main trespasses to physiological hemostasis in an anesthetized patient include the patient's positioning, creation of pneumoperitoneum by the insufflating gas and extubation. These result in complex hemodynamic, pulmonary and metabolic effects on the blood flow, tissue perfusion, and pulmonary mechanics.
Various pharmacological and nonpharmacological methods have been used by the anesthesiologists and surgeons over the years to prevent or attenuate these adverse hemodynamic changes associated with pneumoperitoneum. Many pharmacological agents like adrenoreceptor blockers,  beta blockers,  Ca channel blockers, lidocane,  opioids,  pregabalin,  magnesium sulfate  and vasodilators  have been used to attenuate these responses and improve quality of recovery. However, quest for ideal drug for this purpose and its route of administration continues. 
Clonidine, a centrally acting α2 -adrenergic receptors agonist has sedative, anxiolytic, analgesic properties and stabilizes circulatory system.  It diminishes stress response by reducing circulating catecholamines  and hence increases perioperative circulatory stability  in patients undergoing laparoscopic surgeries. In addition, it increases cardiac baroreflex sensitivity in hypertensive individual, and thus, stabilizes blood pressure by enhancing the role of changes in heart rate. 
Oral clonidine has been commonly employed for hemodynamic control during various laparoscopic studies. ,,, There are few studies demonstrating the effectiveness of intravenous (IV) , or intramuscular (IM) , clonidine individually in attenuation of hemodynamic response during laparoscopy. However, there is limited literature, comparing the intravenous and intramuscular routes of clonidine premedicant in laparoscopic surgery. Hence the present study was undertaken to evaluate the effects of clonidine premedication on the adverse hemodynamic changes that occur during laparoscopic cholecystectomy and also compare the efficacy of IV and IM clonidine premedication.
| Methods|| |
This study was a randomized, double-blind, comparative and prospective study. After approval from the institutional ethical committee and written informed consent, 80 adult patients in the age group of 20-60 yrs., of either sex and of American Society of Anesthesiologists (ASA) grade I or II, posted for elective cholecystectomy under general anesthesia were randomly allocated into two groups using computer-generated randomization list.
Group I - Patients received injection Clonidine 2 μg/kg in 100 ml normal saline as intravenous infusion, 15 minutes prior to anesthesia
Group II - Patients received injection Clonidine 2 μg/kg, intramuscularly, 60-90 minutes prior to anesthesia.
Exclusion criteria included patients with uncontrolled hypertension, ischemic heart disease, chronic reactive airway disease, aortic stenosis, left ventricular failure, AV conduction block, any rhythm other than sinus rhythm, patient's receiving Clonidine/Methyl Dopa/B-blocker/Benzodiazepines/MAO inhibitor, any drug dependence and allergy to Clonidine.
After 6 hours fasting and premedicating with Tab. Diazepam 5 mg on the night prior to surgery, patients were preloaded with 500 ml of lactated ringer's solution in the operation theater prior to induction of anesthesia. Patients assigned to group I received 2 μg/kg of inj. Clonidine in 100 ml of normal saline as intravenous infusion, 15 min prior to the scheduled surgery and those assigned to group II were given 2 μg/kg of inj. Clonidine, intramuscularly, 60-90 min before the scheduled time of surgery. The observer was blinded to the drug being received by the patient.
A standard anesthetic technique was followed for all the patients. Patients were induced with thiopentone sodium 5 mg/kg IV and succinylcholine 1-1.5 mg/kg IV to facilitate tracheal intubation. Anesthesia was maintained with 50% oxygen in nitrous oxide, 0.5-1% isoflurane and injection vecuronium bromide 0.1 mg/kg bolus. This was followed by 0.02 mg/kg for maintenance of muscle relaxation.
Controlled mechanical ventilation with a tidal volume of 8 ml/kg and ventilatory frequency of 14 breaths/min was done to maintain end-tidal carbon dioxide (EtCO 2 ) at 35-45 mmHg and any increase was adjusted with increase in respiratory rate and/or ventilation accordingly.
Pneumoperitoneum was created by insufflation of CO 2 and operation table was tilted to about 15 degrees reverse trendelenburg position. Intra-abdominal pressure (IAP) was maintained between 12-15 mmHg throughout surgical procedure. At the end of the surgery, residual neuromuscular blockade was reversed with neostigmine 0.05 mg/kg and glycopyrrolate 0.01 mg/kg IV after return of protective reflexes.
Intraoperative monitoring included heart rate (HR), continuous electrocardiography, noninvasive systolic (SBP), diastolic (DBP), mean blood pressure (MBP), pulse oximetry (SpO 2 ), and EtCO 2 . The hemodynamic parameters were recorded at the baseline (before premedication), prior to induction, 1 min after intubation, before insufflation of CO 2, after insufflation of CO 2 at 1, 5, 10, 20, 30,45,60 min, after release of CO 2 , at 1 and 10 minutes after extubation. Patients were also observed for drowsiness, dry mouth, skin rashes, nausea and vomiting.
All the episodes of circulatory derangements were recorded. Hypertension (defined as SBP >170 mmHg) was treated with isoflurane (0.20% increments) at 2-minute intervals up to 2% if required. Tachycardia (defined as heart rate >90 beats/min) was treated with bolus dose of fentanyl 25 mcg. Hypotension (defined as SBP <90 mmHg) was treated by reducing the concentration of isoflurane and 250 ml bolus dose of lactated Ringer's solution over 5 minutes followed by ephedrine 6 mg, if the patient was unresponsive. Bradycardia (defined as heart rate <50 beats/min associated with hypotension) was treated with atropine 0.6 mg and repeated once if necessary.
The data collected was tested for normalcy. Normally distributed parametric data was analyzed using unpaired Students 't' test while Chi-square test was performed for categorical data. The data for which the distribution was not normal 'Mann-Whitney' test was used. For comparison within the group, ANOVA test was used. P<0.05 was considered statistically significant.
| Results|| |
The baseline demographic variables and baseline hemodynamic parameters (HR, SBP, DBP, MAP, SpO2) were statistically comparable in between the two groups [Table 1].
|Table 1: Distribution of subjects according to baseline demographic profile and baseline hemodynamic parameters|
Click here to view
In group I, the mean HR varied form 78.88±13.64 beats per min (bpm) to 85.25±11.88 bpm and in group II, the mean HR varied from 80.20±11.77 bpm to 86.53±14.50 bmp [Figure 1]. On comparison within the group, the variation in HR from baseline was not found to be statistically significant (P>0.05) in both the groups. No significant difference was observed in the HR throughout the intra-operative period in between the two groups. On comparison, no significant difference was observed in the highest and the lowest heart rate between the two groups statistically. For bradycardia, five patients in group I and three patients in group II required treatment which was, however, statistically not significant (P=0.46).
Systolic blood pressure
In group I, the mean SBP varied from 112.00±17.99 mm Hg to 125.05±16.17 mm Hg and in group II, the mean SBP varied from 124.33±20.93 mm Hg to 141.75 ± 20.69 mm Hg [Figure 2]. The SBP was maintained near the baseline throughout the intraoperative period in both the groups.
On comparing the change in SBP within the group from baseline, no significant statistical difference was found (P>0.05) except for at 5 minutes after CO 2 insufflation (P=0.021), where it was significant.
A statistically significant difference was noted between the two groups starting from 1 minute after induction till 1 min after extubation (P<0.05). This difference was found to be highly significant at 5 minutes (P<0.0001), 30 minutes (P<0.0001), and 45 minutes after CO 2 insufflation (P<0.0001) and at 1 minute after extubation (P<0.0001) but was found to be statistically comparable at 1 minute after CO 2 insufflation and at 10 minutes after extubation.
Diastolic blood pressure
The mean DBP in group I varied from 80.45±6.57 mmHg (baseline) to 85.50±11.46 (1 min after CO 2 insufflation) and in group II, the mean DBP varied form 80.60±12.53 mmHg (before CO 2 insufflation) to 87.05±10.26 mmHg (at 1 minute after CO 2 insufflation). In both the groups, on intragroup comparative analysis from the baseline DBP, the variation was not found to be significant (P>0.05) [Figure 3].
When the two groups were compared for trends in DBP, the DBP at 1 minute after intubation was found to be significant (P=0.042). There was no other statistically significant difference in DBP throughout the intraoperative period between the two groups.
Mean arterial blood pressure
In group I, the MAP was in the range of 91.03±11.48 mmHg (before CO 2 insufflation) to 98.78±10.75 mmHg (at 10 minutes after CO 2 insufflation) and in group II, the range was from 95.17±14.00 mmHg (before CO 2 insufflation) to 105.27±11.82 mmHg (at 5 minutes post-CO 2 insufflation). On comparison within the group II, the MAP at 5 minutes post-CO 2 insufflation was found to be significant (P=0.020). Apart from this, no statistically significant difference was noted in MAP at any other point within group II intraoperatively [Figure 4].
On statistical comparison in between the two groups, significant difference in MAP was noted at 1 minute after intubation (P=0.004) and then from 5 minutes after CO 2 insufflation to 1 minute after extubation the difference was significant statistically in between the two groups (P<0.05).
The saturation in both the groups was maintained in the range of 96-100% and there was no statistical difference found between the two groups. Normocapnia was maintained throughout the surgery and there was no statistically significant difference between the two groups in EtCO 2 . Overall, adverse effects noted with IV clonidine were statistically less than with IM clonidine (P=0.02). No statistically significant difference was found in between the two groups with regards to individual adverse effect profile [Table 2] except for hypertension. Nine patients (22.5%) in group I and 21 patients (52.5%) in group II had high SBP and DBP that required treatment that was statistically significant (P=0.006).
| Discussion|| |
Alteration in hemodynamic and pulmonary physiology during laparoscopy can be potentially hazardous especially in elderly and patients with comorbidities. The transient acute hemodynamic response which usually occurs at laryngoscopy and tracheal intubation is also seen during insertion of the Veress needle, trocar and during the period of the pneumoperitoneum in patients undergoing laparoscopic surgical procedures. The sympathetic effects associated with insufflation of CO 2 , as well as the shifts in intravascular volume resulting from the Trendelenburg position, can lead to hemodynamic perturbations during surgery. Various studies done over the years have proved these detrimental effects occurring during pneumoperitoneum in the intraoperative period. Various pharmacological and nonpharmacological interventions have been used to re-establish the baseline hemodynamic parameters to allow for safe performance of laparoscopy and clonidine is one of them.
The number of females who underwent laparoscopic cholecystectomy was more when compared to the males in both the groups, this was in consensus with the well established fact that cholecystitis is more common in females and similar to study results of Das M et al.  Dose selection is in consensus with previous studies by Tripathi et al.  We chose to administer IM clonidine 60-90 min prior to induction and IV clonidine 15 min prior to induction. In view of the fact that, clonidine has a half-life of 8-12 hrs with peak effect achieved in 1-1.5 hrs after IM administration and 20 minutes after IV administration. ,, IAP was maintained between 12 and 15 mmHg based upon left ventricle ejection fraction observations by Cunningham et al.  and Dorsay et al. 
Our results show, that the hemodynamic parameters (HR, SBP, DBP, and MAP) were comparable to the baseline in both the groups, thereby, providing stable hemodynamics and protection against stress response triggered by pneumoperitoneum as well as by laryngoscopy and intubation in patients undergoing laparoscopic cholecystectomy. The hemodynamic parameters (SBP, DBP and MAP) were better maintained in the IV as compared to the IM route while the HR was comparable in both the groups. The incidence of hypertension, which required treatment, was significantly higher in the IM group but there were no episodes of hypotension in either group.
Laisalmi et al. found that clonidine (4.5 mcg/kg IM) blunted the deleterious hemodynamic stress response during laparoscopic surgery, had opioid sparing effect and maintained renal integrity.  Joris et al. found that clonidine premedication (8 mcg/kg) IV improved intraoperative and postoperative hemodynamic stability and smoothed the changes in HR, arterial pressure, systemic vascular resistance and cardiac output.  A significant reduction was noted in the HR and MAP when compared to placebo. Reduction in the level of catecholamine and vasopressin following pneumoperitoneum by clonidine is considered responsible for such a change.
Overall, the SBP was maintained near the baseline SBP throughout the surgery with no wide fluctuations during laryngoscopy, surgical incision or pneumoperitoneum in both the groups. The highest SBP was noted after 5-10 min of CO 2 insufflation and the lowest SBP was noted before CO 2 insufflation in both the groups. This inference was corroborated to the study done by Aho et al.  who had studied the effect of IM clonidine on hemodynamic and plasma beta-endorphin responses in 90 patients undergoing gynecologic laparoscopy. The women in the study group received IM clonidine 3 (group I) or 4.5 (group II) mcg/kg, 45-60 minutes before induction of anesthesia while the control group (group III) recieved 2 ml IM saline. In all the groups, the MAP increased after the beginning of laparoscopy but the control group showed a greater increase in MAP than the study group. Thereafter, MAP decreased and was lower than the baseline value indicating that clonidine effectively prevents the maximal hemodynamic responses to tracheal intubation and to gynecologic laparoscopy.
Ray et al.  and Altan et al.  used IV 3 μg/kg clonidine 15 min prior to induction, followed by continuous infusion and found significant incidence of bradycardia and hypotension. We used 2 μg/kg clonidine 15 min prior to induction and gave no intraoperative infusion; hence incidence of hypotension and bradycardia were insignificant. Overall, adverse effects noted with IV clonidine were less than with IM clonidine (P=0.02). Patients receiving IV clonidine had better control of hemodynamics than those receiving IM clonidine as IM group had significantly higher SBP, MAP and more patients with incidence of hypertension requiring treatment. Limitation of the study was that the sample size in our study was small but had significantly important results, and we suggest future studies to be undertaken with a larger population size.
| Conclusions|| |
The results of the study recommends routine use of clonidine premedication in ASA I or II patients undergoing laparoscopic surgery by either route but IV route should be preferred due to better control of hemodynamic changes which occur during laryngoscopy and pneumoperitoneum.
| References|| |
|1.||Matovic E, Hasukic S, Ljuca F, Halilovic H. Quality of life in patients after laparoscopic and open cholecystectomy. Med Arch 2012;66:97-100. |
|2.||Leonard IE, Cunningham AJ. Anaesthetic considerations for laparoscopic cholecystectomy. Best Pract Res Clin Anaesthesiol 2002;16:1-20. |
|3.||Joris JL, Chiche JD, Canivet JL, Jacquet NJ, Legros JJ, Lamy ML. Hemodynamic changes induced by laparoscopy and their endocrine correlates: Effects of clonidine. J Am Coll Cardiol 1998;32:1389-96. |
|4.||Koivusalo AM, Scheinin M, Tikkanen I, Yli-Suomu T, Ristkari S, Laakso J, et al. Effects of esmolol on haemodynamic response to CO2 pneumoperitoneum for laparoscopic surgery. Acta Anaesthesiol Scand 1998;42:510-7. |
|5.||De Oliveira GS Jr, Fitzgerald P, Streicher LF, Marcus RJ, McCarthy RJ. Systemic lidocaine to improve postoperative quality of recovery after ambulatory laparoscopic surgery. Anesth Analg 2012;115:262-7. |
|6.||Lentschener C, Axler O, Fernandez H, Megarbane B, Billard V, Fouqueray B, et al. Haemodynamic changes and vasopressin release are not consistently associated with carbon dioxide pneumoperitoneum in humans. Acta Anaesthesiol Scand 2001;45:527-35. |
|7.||Gupta K, Sharma D, Gupta PK. Oral premedication with pregabalin or clonidine for hemodynamic stability during laryngoscopy and laparoscopic cholecystectomy: A comparative evaluation. Saudi J Anaesth 2011;5:179-84. |
|8.||Jee D, Lee D, Yun S, Lee C. Magnesium sulphate attenuates arterial pressure increase during laparoscopic cholecystectomy. Br J Anaesth 2009;103:484-9. |
|9.||Feig BW, Berger DH, Dougherty TB, Dupuis JF, Hsi B, Hickey RC, et al. Pharmacologic intervention can reestablish baseline hemodynamic parameters during laparoscopy. Surgery 1994;116:733-9. |
|10.||Joris JL, Noirot DP, Legrand MJ, Jacquet NJ, Lamy ML. Hemodynamic changes during laparoscopic cholecystectomy. Anesth Analg 1993;76:1067-71. |
|11.||Gregoretti C, Moglia B, Pelosi P, Navalesi P. Clonidine in perioperative medicine and intensive care unit: More than an anti-hypertensive drug. Curr Drug Targets 2009;10:799-814. |
|12.||Aantaa R, Jalonen J. Perioperative use of alpha2-adrenoceptor agonists and the cardiac patient. Eur J Anaesthesiol 2006;23:361-72. |
|13.||Cividjian A, Toader E, Wesseling KH, Karemaker JM, McAllen R, Quintin L. Effect of clonidine on cardiac baroreflex delay in humans and rats. Am J Physiol Regul Integr Comp Physiol 2011;300:R949-57. |
|14.||Singh S, Arora K. Effect of oral clonidine premedication on perioperative haemodynamic response and postoperative analgesic requirement for patients undergoing laparoscopic cholecystectomy. Indian J Anaesth 2011;55:26-30. |
|15.||Sung CS, Lin SH, Chan KH, Chang WK, Chow LH, Lee TY. Effect of oral clonidine premedication on perioperative hemodynamic response and postoperative analgesic requirement for patients undergoing laparoscopic cholecystectomy. Acta Anaesthesiol Sin 2000;38:23-9. |
|16.||Yu HP, Hseu SS, Yien HW, Teng YH, Chan KH. Oral clonidine premedication preserves heart rate variability for patients undergoing larparoscopic cholecystectomy. Acta Anaesthesiol Scand 2003;47:185-90. |
|17.||Tripathi DC, Shah KS, Dubey SR, Doshi SM, Raval PV. Hemodynamic stress response during laparoscopic cholecystectomy: Effect of two different doses of intravenous clonidine premedication. J Anaesthesiol Clin Pharmacol 2011;27:475-80. |
|18.||Kalra NK, Verma A, Agarwal A, Pandey H. Comparative study of intravenously administered clonidine and magnesium sulfate on hemodynamic responses during laparoscopic cholecystectomy. J Anaesthesiol Clin Pharmacol 2011;27:344-8. |
|19.||Málek J, Knor J, Kurzová A, Lopourová M. Adverse hemodynamic changes during laparoscopic cholecystectomy and their possible suppression with clonidine premedication. Comparison with intravenous and intramuscular premedication. Rozhl Chir 1999;78:286-91. |
|20.||Laisalmi M, Koivusalo AM, Valta P, Tikkanen I, Lindgren L. Clonidine provides opioid-sparing effect, stable hemodynamics, and renal integrity during laparoscopic cholecystectomy. Surg Endosc 2001;15:1331-5. |
|21.||Das M, Ray M, Mukherjee G. Haemodynamic changes during laparoscopic cholecystectomy: Effect of Clonidine premedication. Indian J Anaesthesiol 2007;51:205-10. |
|22.||Moss J, Glick D. The Autonomic Nervous System. Miller's Anaesthesia, 6 th ed. In: Miller RD, editor. Philadelphia: Elsevier Churchill Livingstone Publishers; 2005. p. 617-77. |
|23.||Joris JL. Anaesthesia for Laparoscopic surgery. Miller's Anaesthesia, 6 th ed. In: Miller RD, editor. Philadelphia: Elsevier Churchill Livingstone Publishers; 2005. p. 2285-93. |
|24.||Stoelting RK, Hellier SC. Antihypertensive Drugs. In: Pharmacology and Physiology in Anaesthetic Practice, 4 th ed. Philadelphia: Lippincot Williams and Wilkins; 2006. p. 340-4. |
|25.||Cunningham AJ, Turner J, Rosenbaum S, Rafferty T. Transoesophageal echocardiographic assessment of haemodynamic function during laparoscopic cholecystectomy. Br J Anaesth 1993;70:621-5. |
|26.||Dorsay DA, Greene FL, Baysinger CL. Hemodynamic changes during laparoscopic cholecystectomy monitored with transesophageal echocardiography. Surg Endosc 1995;9:128-33. |
|27.||Aho M, Lehtinen AM, Laatikainen T, Korttila K. Effects of intramuscular clonidine on hemodynamic and plasma beta-endorphin responses to gynecologic laparoscopy. Anesthesiology 1990;72:797-802. |
|28.||Ray M, Bhattacharjee DP, Hajra B, Pal R, Chatterjee N. Effect of clonidine and magnesium sulphate on anaesthetic consumption, haemodynamics and postoperative recovery: A comparative study. Indian J Anaesth 2010;54:137-41. |
|29.||Altan A, Turgut N, Yildiz F, Türkmen A, Ustün H. Effects of magnesium sulphate and clonidine on propofol consumption, haemodynamics and postoperative recovery. Br J Anaesth 2005;94:438-41. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
[Table 1], [Table 2]
|This article has been cited by|
||Comparison between intravenous and intratecal clonidine for postoperative analgesia of patients submitted to laparoscopic cholecystectomy: randomized clinical trial
| ||Christiane Rodrigues da Silva, Cinthya Iamile Frithz Brandão de Oliveira, Juscimar Carneiro Nunes |
| ||Brazilian Journal of Anesthesiology (English Edition). 2021; |
|[Pubmed] | [DOI]|
||To study the efficacy and post-operative sedation in intravenous and intrathecal clonidine in patients undergoing laproscopic assisted vaginal hysterectomy under general anesthesia
| ||Asha G, Geethanjali S Masamaddi, Amith S |
| ||Indian Journal of Clinical Anaesthesia. 2021; 8(1): 24 |
|[Pubmed] | [DOI]|
||Evaluating the effect of intramuscular dexmedetomidine or clonidine on the duration of anaesthesia and analgesia for lower abdominal surgeries under sub-arachnoid block
| ||Shailaja S, Sasha MM |
| ||Indian Journal of Clinical Anaesthesia. 2020; 7(1): 182 |
|[Pubmed] | [DOI]|
||Alpha-2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery
| ||Dallas Duncan, Ashwin Sankar, W Scott Beattie, Duminda N Wijeysundera |
| ||Cochrane Database of Systematic Reviews. 2018; 2018(9) |
|[Pubmed] | [DOI]|
||What is the place of clonidine in anesthesia? Systematic review and meta-analyses of randomized controlled trials
| ||Miguel Carlos Sanchez Munoz, Marc De Kock, Patrice Forget |
| ||Journal of Clinical Anesthesia. 2017; 38: 140 |
|[Pubmed] | [DOI]|